657P Prospective validation of the T cell engager (TCE) score in patients treated with bispecific CD3 TCE antibodies in phase I clinical trials
| Autor: | Herbel, N., Ouali, K., Danlos, F-X., Massard, C.P., Goldschmidt, V., Michot, J-M., Laparra, A., Bernard-Tessier, A., Gazzah, A., Bahleda, R., Hollebecque, A., Henon, C., Postel-Vinay, S., Loriot, Y., Ribrag, V., Marabelle, A., Fizazi, K., Ponce Aix, S., Champiat, S., Baldini, C. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S519-S519 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|